Involvement of drug-specific t cells in acute drug-induced interstitial nephritis

Journal of the American Society of Nephrology

Volumn 17, Issue 10, 2006, Pages 2919-2927

  Spanou, Zoi ^a   Keller, Monika ^a   Britschgi, Markus ^a   Yawalkar, Nikhil ^b   Fehr, Thomas ^d   Neuweiler, Jörg ^d   Gugger, Mathias ^c   Mohaupt, Markus ^b   Pichler, Werner J ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; C REACTIVE PROTEIN; CD4 ANTIGEN; CD68 ANTIGEN; CREATININE; CYTOKINE; DICLOFENAC; DISULFIRAM; FAS ANTIGEN; FLUCLOXACILLIN; GENTAMICIN; GLIBENCLAMIDE; INDOMETACIN; INTERLEUKIN 12; INTERLEUKIN 5; IRBESARTAN; LIVER ENZYME; PENICILLIN G; PERFORIN; RECOMBINANT INTERLEUKIN 2; RIFAMPICIN; T LYMPHOCYTE RECEPTOR; VANCOMYCIN;

ACUTE DISEASE; AGED; ANTIGEN EXPRESSION; ARTICLE; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY TEST; DRUG HYPERSENSITIVITY; EOSINOPHIL; EOSINOPHILIA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; LEUKOCYTURIA; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFORMATION TEST; MALE; NEUTROPHIL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEINURIA; PYURIA; RASH; SIDE EFFECT; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

EID: 33749242789     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006050418     Document Type: Article

References (33)

1. Strutz F, Neilson EG: The role of lymphocytes in the progression of interstitial disease. Kidney Int Suppl 45: S106-S110, 1994
2. Zakheim B, McCafferty E, Phillips SM, Clayman M, Neilson EG: Murine interstitial nephritis. 11. The adoptive transfer of disease with immune T lymphocytes produces a phenotypically complex interstitial lesion. J Immunol 133: 234-239, 1984
3. Pichler WJ: Delayed drug hypersensitivity reactions. Ann Intern Med 139: 683-693, 2003
4. Markowitz GS, Perazella MA: Drug-induced renal failure: A focus on tubulointerstitial disease. Clin Chim Acta 351: 31-47, 2005
5. Neilson EG: Pathogenesis and therapy of interstitial nephritis. Kidney Int 35: 1257-1270, 1989
6. Pusey CD, Lockwood CM, Peters DK: Plasma exchange and immunosuppressive drugs in the treatment of glomerulonephritis due to antibodies to the glomerular basement membrane. Int J Artif Organs 6[Suppl 1]: 15-18, 1983
7. Yawalkar N, Pichler WJ: Immunohistology of drug-induced exanthema: Clues to pathogenesis. Curr Opin Allergy Clin Immunol 1: 299-303, 2001
8. Britschgi M, Pichler WJ: Acute generalized exanthematous pustulosis, a clue to neutrophil-mediated inflammatory processes orchestrated by T cells. Curr Opin Allergy Clin Immunol 2: 325-331, 2002
9. Schaerli P, Britschgi M, Keller M, Steiner UC, Steinmann LS, Moser B, Pichler WJ: Characterization of human T cells that regulate neutrophilic skin inflammation. J Immunol 173: 2151-2158, 2004
10. Britschgi M, von Greyerz S, Burkhart C, Pichler WJ: Molecular aspects of drug recognition by specific T cells. Curr Drug Targets 4: 1-11, 2003
11. Naisbitt DJ, Britschgi M, Wong G, Farrell J, Depta JP, Chadwick DW, Pichler WJ, Pirmohamed M, Park BK: Hypersensitivity reactions to carbamazepine: Characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. Mol Pharmacol 63: 732-741, 2003
12. Griem P, Wulferink M, Sachs B, Gonzalez JB, Gleichmann E: Allergic and autoimmune reactions to xenobiotics: How do they arise? Immunol Today 19: 133-141, 1998
13. Border WA, Lehman DH, Egan JD, Sass HJ, Glode JE, Wilson CB: Antitubular basement-membrane antibodies in methicillin-associated interstitial nephritis. N Engl J Med 291: 381-384, 1974
14. Schnyder B, Mauri-Hellweg D, Zanni M, Bettens F, Pichler WJ: Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones. J Clin Invest 100: 136-141, 1997
15. Naisbitt DJ, Gordon SF, Pirmohamed M, Burkhart C, Cribb AE, Pichler WJ, Park BK: Antigenicity and immunogenicity of sulphamethoxazole: Demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo. Br J Pharmacol 133: 295-305, 2001
16. Naisbitt DJ, Farrell J, Gordon SF, Maggs JL, Burkhart C, Pichler WJ, Pirmohamed M, Park BK: Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation. Mol Pharmacol 62: 628-637, 2002
17. Van Vleet TR, Schnellmann RG: Toxic nephropathy: Environmental chemicals. Semin Nephrol 23: 500-508, 2003
18. Pichler WJ: Pharmacological interaction of drugs with antigen-specific immune receptors: The p-i concept. Curr Opin Allergy Clin Immunol 2: 301-305, 2002
19. Gerber BO, Pichler WJ: Cellular mechanisms of T cell mediated drug hypersensitivity. Curr Opin Immunol 16: 732-737, 2004
20. Pichler WJ, Tilch J: The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 59: 809-820, 2004
21. Zanni MP, Mauri-Hellweg D, Brander C, Wendland T, Schnyder B, Frei E, von Greyerz S, Bircher A, Pichler WJ: Characterization of lidocaine-specific T cells. J Immunol 158: 1139-1148, 1997
22. Yawalkar N, Egli F, Hari Y, Nievergelt H, Braathen LR, Pichler WJ: Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions. Clin Exp Allergy 30: 847-855, 2000
23. Yawalkar N, Shrikhande M, Hari Y, Nievergelt H, Braathen LR, Pichler WJ: Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions. J Allergy Clin Immunol 106: 1171-1176, 2000
24. van den Beemd R, Boor PP, van Lochern EG, Hop WC, Langerak AW, Wolvers-Tettero IL, Hooijkaas H, van Dongen JJ: Flow cytometric analysis of the Vbeta repertoire in healthy controls. Cytometry 40: 336-345, 2000
25. Schmid S, Kuechler PC, Britschgi M, Steiner UC, Yawalkar N, Limat A, Baltensperger K, Braathen L, Pichler WJ: Acute generalized exanthematous pustulosis: Role of cytotoxic T cells in pustule formation. Am J Pathol 161: 2079-2086, 2002
26. Beeler A, Engler O, Gerber BO, Pichler WJ: Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions. J Allergy Clin Immunol 117: 455-462, 2006
27. Keller M, Spanou Z, Schaerli P, Britschgi M, Yawalkar N, Seitz M, Villiger PM, Pichler WJ: T cell-regulated neutrophilic inflammation in autoinflammatory diseases. J Immunol 175: 7678-7686, 2005
28. Britschgi M, Steiner UC, Schmid S, Depta JP, Senti G, Bircher A, Burkhart C, Yawalkar N, Pichler WJ: T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest 107: 1433-1441, 2001
29. Schnyder B, Frutig K, Mauri-Hellweg D, Limat A, Yawalkar N, Pichler WJ: T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction. Clin Exp Allergy 28: 1412-1417, 1998
30. Kuechler PC, Britschgi M, Schmid S, Hari Y, Grabscheid B, Pichler WJ: Cytotoxic mechanisms in different forms of T-cell-mediated drug allergies. Allergy 59: 613-622, 2004
31. Gell PGH, Coombs RRA: Classification of allergic reactions responsible for clinical hypersensitivity and disease. In: Clinical Aspects of Immunology, Oxford, Blackwell, 1963, pp 317-337
32. Yawalkar N, Pichler WJ: Pathogenesis of drug-induced exanthema. Int Arch Allergy Immunol 124: 336-338, 2001
33. Schneider CH, de Weck AL: Chemical aspects of penicillin allergy. The direct penicilloylation of epsilon-amino groups by penicillin at pH 7.4. Helv Own Acta 49: 1695-1706, 1966